The FBI and Justice officials closed the investigation, which a Justice Department appointee had called a “deep state” probe in early 2025.
www.msnbc.com
Trump administration set to tie Tylenol to autism risk, officials say
Officials will also tout the drug leucovorin as a potential autism treatment, in what President Donald Trump has billed as a “very important” announcement.
The Trump administration is expected to unveil new efforts Monday exploring how
one medication may be linked to autism and another one can treat it, according to four people with knowledge of the plans who spoke on the condition of anonymity because the announcement was not yet public. Federal health officials are expected to raise concerns about pregnant women’s use of acetaminophen, the active ingredient in Tylenol and one of the most widely used medications globally. Officials have been reviewing previous research — including an August review by Mount Sinai and Harvard researchers — that suggests a possible link between Tylenol use early on in pregnancy and an increased risk of autism in children. They plan to warn pregnant women against using Tylenol early on unless they have a fever, according to the four individuals. In addition, officials plan to tout a lesser-known drug called leucovorin as a potential autism treatment. Leucovorin is typically prescribed to counteract some medications’ side effects and to treat vitamin B9 deficiency. Early double-blind, placebo-controlled trials administering leucovorin to children with autism have shown what some scientists describe as remarkable improvements in their ability to speak and understand others. Officials at the Food and Drug Administration have recently been reviewing language that could apply to the drug. The findings on leucovorin have sent ripples through the scientific community, sparking renewed debate about the complex causes of autism — a condition some experts had recently considered predominantly genetic, and therefore largely untreatable. The efforts have been a top priority for President Donald Trump, who has long voiced concerns about rising U.S. autism rates and tasked his deputies this year with finding answers. The initiative has drawn in Health and Human Services Secretary Robert F. Kennedy Jr., Food and Drug Administration Commissioner Marty Makary, National Institutes of Health Director Jay Bhattacharya and other senior officials. Trump on Saturday forecast an announcement on autism, but he — and the officials — did not specify how it would be delivered. “I think it’s going to be a very important announcement. I think it’s going to be one of the most important things that we will do,” Trump said at an event Saturday hosted by the conservative American Cornerstone Institute.